Time for a “Third Wave” of Malaria Activism to Tackle the Drug Stock-out Crisis
Open Access
- 24 November 2009
- journal article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 6 (11), e1000188
- https://doi.org/10.1371/journal.pmed.1000188
Abstract
The PLoS Medicine Editors discuss shortages of artemisinin-based combination therapy in Africa at the point of care and how these can be addressed.Keywords
This publication has 18 references indexed in Scilit:
- Piloting the Global Subsidy: The Impact of Subsidized Artemisinin-Based Combination Therapies Distributed through Private Drug Shops in Rural TanzaniaPLOS ONE, 2009
- Focusing on Quality Patient Care in the New Global Subsidy for Malaria MedicinesPLoS Medicine, 2009
- Time To Move from Presumptive Malaria Treatment to Laboratory-Confirmed Diagnosis and Treatment in African Children with FeverPLoS Medicine, 2009
- Malaria case-management under artemether-lumefantrine treatment policy in UgandaMalaria Journal, 2008
- Divergent Goals and Commitments in Global Malaria InterventionPLoS Medicine, 2008
- International Funding for Malaria Control in Relation to Populations at Risk of Stable Plasmodium falciparum TransmissionPLoS Medicine, 2008
- Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional studyMalaria Journal, 2007
- Global fund changes tack on malaria therapyNature, 2004
- Health agencies end in-fighting on malariaBMJ, 2004
- Malaria researchers say global fund is buying "useless drug"BMJ, 2003